S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Modern Day Options Trading For Beginners! (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Modern Day Options Trading For Beginners! (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Modern Day Options Trading For Beginners! (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Modern Day Options Trading For Beginners! (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Modern Day Options Trading For Beginners! (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Modern Day Options Trading For Beginners! (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Modern Day Options Trading For Beginners! (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Modern Day Options Trading For Beginners! (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
NASDAQ:RXRX

Recursion Pharmaceuticals - RXRX Insider Trading & Ownership

$6.77
-0.21 (-3.01%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$6.43
▼
$7.08
50-Day Range
$6.77
▼
$9.64
52-Week Range
$4.92
▼
$14.18
Volume
2.18 million shs
Average Volume
983,524 shs
Market Capitalization
$1.29 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.80

Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.25%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$4.44 M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$7.33 M

RXRX Insider Buying and Selling by Quarter

Get RXRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Recursion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Recursion Pharmaceuticals Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/21/2023Blake BorgesonDirectorSell8,885$7.40$65,749.007,576,287  
3/8/2023Christopher GibsonCEOSell70,890$8.10$574,209.00963,787  
3/7/2023Blake BorgesonDirectorSell8,885$8.33$74,012.057,585,172  
3/2/2023Christopher GibsonCEOSell18,500$7.92$146,520.00940,927  
2/27/2023Mubadala Investment Co PjscMajor ShareholderBuy52,500$7.69$403,725.0012,869,423  
2/23/2023Mubadala Investment Co PjscMajor ShareholderBuy51,864$7.79$404,020.5612,707,805  
2/23/2023Tina Marriott LarsonCOOSell8,000$7.82$62,560.00427,844  
2/21/2023Blake BorgesonDirectorSell8,885$7.73$68,681.057,594,057  
2/21/2023Mubadala Investment Co PjscMajor ShareholderBuy94,418$7.74$730,795.3212,605,000  
2/16/2023Mubadala Investment Co PjscMajor ShareholderBuy42,682$7.90$337,187.8012,447,200  
2/15/2023Shafique ViraniInsiderSell7,486$8.33$62,358.38189,846  
2/14/2023Mubadala Investment Co PjscMajor ShareholderBuy6,300$7.95$50,085.0012,404,518  
2/10/2023Mubadala Investment Co PjscMajor ShareholderBuy11,000$7.98$87,780.0012,365,744  
2/7/2023Blake BorgesonDirectorSell8,885$8.81$78,276.857,602,942  
1/26/2023Tina Marriott LarsonCOOSell8,000$8.07$64,560.00203,654  
1/25/2023Mubadala Investment Co PjscMajor ShareholderBuy24,526$7.88$193,264.8812,346,258  
1/24/2023Blake BorgesonDirectorSell8,885$8.71$77,388.357,611,827  
1/17/2023Shafique ViraniInsiderSell10,000$9.16$91,600.0073,160  
1/10/2023Blake BorgesonDirectorSell8,885$7.69$68,325.657,620,712  
1/9/2023Mubadala Investment Co PjscMajor ShareholderBuy76,046$7.64$580,991.4412,252,214  
1/5/2023Christopher GibsonCEOSell18,500$7.39$136,715.00525,805  
1/5/2023Mubadala Investment Co PjscMajor ShareholderBuy80,035$7.38$590,658.3012,107,215  
1/3/2023Mubadala Investment Co PjscMajor ShareholderBuy141,646$7.50$1,062,345.0011,935,288  
12/29/2022Tina Marriott LarsonCOOSell8,000$7.70$61,600.00203,654  
12/27/2022Blake BorgesonDirectorSell8,885$7.25$64,416.257,628,272  
12/15/2022Shafique ViraniInsiderSell10,000$8.85$88,500.0078,160  
12/13/2022Blake BorgesonDirectorSell8,885$8.96$79,609.607,637,157  
12/1/2022Christopher GibsonCEOSell37,210$9.02$335,634.20582,805  
11/29/2022Blake BorgesonDirectorSell8,885$8.75$77,743.757,646,042  
11/17/2022Tina Marriott LarsonCOOSell16,000$10.96$175,360.00203,654  
11/16/2022Blake BorgesonDirectorSell17,770$11.12$197,602.407,654,927  
11/15/2022Shafique ViraniInsiderSell10,000$12.31$123,100.0083,160  
11/3/2022Christopher GibsonCEOSell36,693$10.00$366,930.00576,016  
10/27/2022Tina Marriott LarsonCOOSell16,000$10.72$171,520.00205,107  
10/14/2022Shafique ViraniInsiderSell10,000$10.92$109,200.0088,773  
10/6/2022Christopher GibsonCEOSell36,053$11.58$417,493.74562,959  
9/29/2022Tina Marriott LarsonCOOSell16,000$10.86$173,760.00205,107  
9/15/2022Shafique ViraniInsiderSell10,000$13.36$133,600.0093,773  
8/16/2022Shafique ViraniInsiderSell30,000$12.61$378,300.0098,773  
8/16/2022Tina Marriott LarsonCOOSell16,000$12.60$201,600.00295,107  
8/4/2022Christopher GibsonCEOSell36,825$9.49$349,469.25541,829  
7/7/2022Christopher GibsonCEOSell37,114$9.05$335,881.70528,904  
6/2/2022Christopher GibsonCEOSell39,690$6.09$241,712.10516,268  
5/4/2022Christopher GibsonCEOSell31,830$6.49$206,576.70511,972  
4/28/2022Christopher GibsonCEOSell37,605$6.09$229,014.45469,608  
4/21/2022Christopher GibsonCEOSell37,155$6.31$234,448.05420,146  
4/18/2022Christopher GibsonCEOSell35,836$6.84$245,118.24394,791  
4/14/2022Christopher GibsonCEOSell34,517$7.56$260,948.52368,117  
4/7/2022Christopher GibsonCEOSell36,718$6.54$240,135.72314,534  
4/5/2022Christopher GibsonCEOSell34,472$7.43$256,126.96288,742  
(Data available from 1/1/2013 forward)












RXRX Insider Trading Activity - Frequently Asked Questions

Who is on Recursion Pharmaceuticals's Insider Roster?

The list of insiders at Recursion Pharmaceuticals includes Blake Borgeson, Christopher Gibson, Dean Y Li, Mubadala Investment Co Pjsc, Shafique Virani, and Tina Marriott Larson. Learn more on insiders at RXRX.

What percentage of Recursion Pharmaceuticals stock is owned by insiders?

22.25% of Recursion Pharmaceuticals stock is owned by insiders. Learn more on RXRX's insider holdings.

Which Recursion Pharmaceuticals insiders have been buying company stock?

The following insider purchased RXRX shares in the last 24 months: Mubadala Investment Co Pjsc ($4,440,853.30).

How much insider buying is happening at Recursion Pharmaceuticals?

Insiders have purchased a total of 581,017 RXRX shares in the last 24 months for a total of $4,440,853.30 bought.

Which Recursion Pharmaceuticals insiders have been selling company stock?

The following insiders have sold RXRX shares in the last 24 months: Blake Borgeson ($1,401,392.45), Christopher Gibson ($11,499,804.58), Dean Y Li ($384,919.84), Shafique Virani ($986,658.38), and Tina Marriott Larson ($1,005,110.00).

How much insider selling is happening at Recursion Pharmaceuticals?

Insiders have sold a total of 1,747,173 Recursion Pharmaceuticals shares in the last 24 months for a total of $15,277,885.25 sold.

This page (NASDAQ:RXRX) was last updated on 3/24/2023 by MarketBeat.com Staff